NDC 68180-210-01 - Losartan Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68180-210
- Requested NDC
- 68180-210-01
- Package NDCs from labels
- 68180-210-09, 68180-210-03, 68180-210-01, 68180-210-06
- Manufacturer
- Lupin Pharmaceuticals, Inc. | LUPIN LIMITED
- Effective date
- 2026-06-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium - Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2026-06-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68180-210-01 | Losartan Potassium | 100 in 1 BOTTLE | TABLET | 100 | 25 | |
| 68180-210-03 | Losartan Potassium | 1000 in 1 BOTTLE | TABLET | 1000 | 25 | |
| 68180-210-06 | Losartan Potassium | 30 in 1 BOTTLE | TABLET | 30 | 25 | |
| 68180-210-09 | Losartan Potassium | 90 in 1 BOTTLE | TABLET | 90 | 25 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68180-210-03 | EA - Each | 68180-210 | 3b4cd537-cff9-43b8-a382-e9ea79a8d043 | 1 | 2012-07-24 |
| 68180-210-09 | EA - Each | 68180-210 | b76cfa67-ed03-467a-9881-3560ac063b27 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 6 | ENSULIZOLE,HOMOSALATE ,OCTINOXATE ,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3e069cb2-c4c5-abf5-e063-6394a90a56b0 | 2025-09-06 | Warnings | 15FIX9V2JP |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | NorthStar Rx LLC | 25318baf-9c2f-458f-b9ea-f52dabca49af | 2025-09-06 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b52f29-c1a0-c673-e063-6294a90a9a7a | 2025-09-05 | Warnings | 15FIX9V2JP |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b8003f-40be-3380-e063-6294a90a4f6b | 2025-09-05 | Warnings | 15FIX9V2JP |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 0e015b9a-0ac1-4ec3-bbe7-7a672d30e1f4 | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30, 1 | ENSULIZOLE, HOMOSALATE, OCTINOXATE, TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 18130858-429c-4ed4-a75b-5bc014481250 | 2025-09-04 | Warnings | 15FIX9V2JP |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8d56b5db-e72d-4f09-aed4-09e65a27e9ff | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan potassium Tablets, 100 mg | LOSARTAN POTASSIUM | Bryant Ranch Prepack | 04c4ba11-a9bd-4fed-bf14-14214f33f9c2 | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | 979480 3ST302B24A |
| Losartan potassium Tablets, 25 mg | LOSARTAN POTASSIUM | Bryant Ranch Prepack | ee58207e-3913-4262-87ec-930bb4ecf07b | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | 979485 3ST302B24A |
| Dolce and Gabbana Everlast Foundation SPF 20 38C Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 0358a87d-8002-4f3e-851a-3a582d356edf | 2025-09-03 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 39N Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 34dfc4c5-44f7-4531-97ba-8846ebe14724 | 2025-09-03 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 40C Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | cf4b6f45-d4ae-4665-87b4-c5af4910befa | 2025-09-03 | Warnings | 15FIX9V2JP |
| Pure6 ManiShield Hand Screen | ZINC OXIDE, TITANIUM DIOXIDE | GUANGZHOU SAWEILAN IMPORT & EXPORT TRADING CO., LTD | 3abcb6ba-1de8-55e7-e063-6294a90aecf1 | 2025-09-02 | Warnings | 15FIX9V2JP |
| toty Ilumina CC Creamy Compact 6N | TITANIUM DIOXIDE | Chipican LLC | 3da732e7-19b0-3195-e063-6394a90a9a0c | 2025-09-01 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 4 | ENSULIZOLE ,HOMOSALATE,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3dba1360-f70f-e450-e063-6394a90a8c9f | 2025-09-01 | Warnings | 15FIX9V2JP |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | be81ba65-c434-4287-97d3-cd11d6031636 | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Dolce and Gabbana Everlast Foundation SPF 20 33N Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | e249507c-d536-4c1d-a99d-857ca1e833d8 | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 32W Medium Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | ba99edea-bf68-4118-8bb7-ea40322db46a | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 34W Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3a239897-9850-417f-8c00-e810a52540c1 | 2025-08-29 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 36N Deep | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | c495afc3-6486-4652-b743-958f28eccaca | 2025-08-29 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.